Istituti Clinici Scientifici Maugeri IRCCS, Cardiac Rehabilitation of the Institute of Lumezzane, Brescia, Italy.
Istituti Clinici Scientifici Maugeri IRCCS, Scientific Direction of the Institute of Lumezzane, Brescia, Italy.
J Clin Nurs. 2021 Apr;30(7-8):952-960. doi: 10.1111/jocn.15637. Epub 2021 Feb 3.
To document the level of frailty in sub-acute COVID-19 patients recovering from acute respiratory failure and investigate the associations between frailty, assessed by the nurse using the Blaylock Risk Assessment Screening Score (BRASS), and clinical and functional patient characteristics during hospitalisation.
Frailty is a major problem in patients discharged from acute care, but no data are available on the frailty risk in survivors of COVID-19 infection.
A descriptive cross-sectional study (STROBE checklist).
At admission to sub-acute care in 2020, 236 COVID-19 patients (median age 77 years - interquartile range 68-83) were administered BRASS and classified into 3 levels of frailty risk. The Short Physical Performance Battery (SPPB) was also administered to measure physical function and disability. Differences between BRASS levels and associations between BRASS index and clinical parameters were analysed.
The median BRASS index was 14.0 (interquartile range 9.0-20.0) denoting intermediate frailty (32.2%, 41.1%, 26.7% of patients exhibited low, intermediate and high frailty, respectively). Significant differences emerged between the BRASS frailty classes regards to sex, comorbidities, history of cognitive deficits, previous mechanical ventilation support and SPPB score. Patients with no comorbidities (14%) exhibited low frailty (BRASS: median 5.5, interquartile range 3.0-12.0). Age ≥65 years, presence of comorbidities, cognitive deficit and SPPB % predicted <50% were significant predictors of high frailty.
Most COVID-19 survivors exhibit substantial frailty and require continuing care after discharge from acute care.
The BRASS index is a valuable tool for nurses to identify those patients most at risk of frailty, who require a programme of rehabilitation and community reintegration.
记录从急性呼吸衰竭中康复的亚急性 COVID-19 患者的虚弱程度,并调查护士使用布莱洛克风险评估筛查评分(BRASS)评估的虚弱程度与住院期间患者临床和功能特征之间的关系。
虚弱是急性护理出院患者的主要问题,但 COVID-19 感染幸存者的脆弱性风险尚无数据。
描述性横断面研究(STROBE 清单)。
在 2020 年进入亚急性护理时,对 236 名 COVID-19 患者(中位数年龄 77 岁-四分位距 68-83)进行 BRASS 评估,并将其分为 3 个脆弱性风险等级。还进行了简短体能表现电池测试(SPPB)以测量身体功能和残疾。分析 BRASS 水平之间的差异以及 BRASS 指数与临床参数之间的关系。
BRASS 指数中位数为 14.0(四分位距 9.0-20.0),表示中度虚弱(分别有 32.2%、41.1%和 26.7%的患者表现为低、中、高脆弱性)。BRASS 脆弱性等级之间存在显著差异,涉及性别、合并症、认知缺陷史、先前的机械通气支持和 SPPB 评分。无合并症的患者(14%)表现出低脆弱性(BRASS:中位数 5.5,四分位距 3.0-12.0)。年龄≥65 岁、存在合并症、认知缺陷和 SPPB%预测值<50%是高脆弱性的显著预测因素。
大多数 COVID-19 幸存者表现出明显的虚弱,需要在急性护理出院后继续护理。
BRASS 指数是护士识别最易患脆弱性的患者的有用工具,这些患者需要康复和社区融入计划。